David Helekal

7PUBLICATIONS
11CO-AUTHORS
Health and ecological risk assessmentObstetrics and gynaecologyMedical bacteriologyMolecular evolutionNetwork engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 18, 2026
Fluoroquinolone resistance-conferring gyrA variants alter the fitness cost and potentiate the resistance of the zoliflodacin resistance mutation gyrB D429N in Neisseria gonorrhoeae.

|Mar 20, 2026
Genetic background modulates zoliflodacin and gepotidacin cross-resistance and fitness in Neisseria gonorrhoeae.

Aditi Mukherjee, Sofia O P Blomqvist, David Helekal

|Jan 08, 2026
Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study.

Madeleine C Kline, Kirstin Oliveira Roster, David Helekal

|Dec 15, 2025
Zoliflodacin and gepotidacin cross-resistance in Neisseria gonorrhoeae.

Aditi Mukherjee, Sofia Op Blomqvist, David Helekal

|Jul 09, 2025
Expansion of tetM-Carrying Neisseria gonorrhoeae in the United States, 2018-2024.

David Helekal, Tatum D Mortimer, Yonatan H Grad

|Jul 09, 2025
Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study.

Madeleine C Kline, Kirstin Oliveira Roster, David Helekal

Pageof 2

Frequent Collaborators

7 joint publications

Yonatan H Grad

4 joint publications

Aditi Mukherjee

4 joint publications

Samantha G Palace

3 joint publications

Sofia Op Blomqvist